Trials / Completed
CompletedNCT04654702
Observational Study to Evaluate Therapeutic Effectiveness and Safety of Monterizine Cap.
A Multi-center, Prospective, Observational Study to Evaluate Therapeutic Effectiveness and Safety of Monterizine Cap in Patients With Asthma and Perennial Allergic Rhinitis.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,671 (actual)
- Sponsor
- Hanmi Pharmaceutical Company Limited · Industry
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
Investigator examines the past prescription patterns and the reasons for the change of prescription to Monterizine capsules for Perennial Allergic Rhinitis patients with Asthma who will be taking Monterizine capsules to treat allergic rhinitis. After being given Monterizine capsules, Investigator evaluates the therapeutic effectiveness and safety for 3 months (or 6 months).
Detailed description
A Multi-center, Prospective, Observational Study
Conditions
Timeline
- Start date
- 2017-11-17
- Primary completion
- 2020-01-10
- Completion
- 2020-07-20
- First posted
- 2020-12-04
- Last updated
- 2021-11-26
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04654702. Inclusion in this directory is not an endorsement.